IDEAYA Biosciences, Inc. IDYA Net Change in Cash
Net Change in Cash at other companies
Other financials
Where this comes from
Reported directly by IDEAYA Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.
The official record: IDEAYA Biosciences, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about IDEAYA Biosciences, Inc.'s net change in cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is IDEAYA Biosciences, Inc.'s net change in cash?
- IDEAYA Biosciences, Inc. (IDYA) reported net change in cash of $44.96M in Q1 2026.
- How has IDEAYA Biosciences, Inc.'s net change in cash changed year-over-year?
- IDEAYA Biosciences, Inc.'s net change in cash decreased by 1.4% year-over-year, from $45.62M to $44.96M.
- What is the long-term trend for IDEAYA Biosciences, Inc.'s net change in cash?
- Over 2 years (2022 to 2024), IDEAYA Biosciences, Inc.'s net change in cash has grown at a 76.1% compound annual growth rate (CAGR), from -$23.41M to -$72.59M.
- What does net change in cash mean?
- Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.